Definium Therapeutics Announces Positive Topline Results from Phase 3 Voyage Study of DT120 ODT in Generalized Anxiety Disorder

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. PANW
3. CL
4. SNDK
5. TAP
6. DELL
7. ROIV
8. ANET
9. NKE
10. BLDR

Go back to Definium Therapeutics Announces Positive Topline Results from Phase 3 Voyage Study of DT120 ODT in Generalized Anxiety Disorder
(NASDAQ: DFTX) Delayed: 38.09 +0.09 (0.24%)
Previous Close $38.00    52 Week High $ 
Open $37.94    52 Week Low $ 
Day High $38.54    P/E N/A 
Day Low $37.38    EPS $ 
Volume 1,128,929